The 4-oxospiro[benzopyran-2,4'-piperidine] ring system is contained within potent class III antiarrhythmic agents. We highlight how these agents can be chemically transformed into a new class of potent (1 nM) and selective (25-fold) alpha 1a-receptor subtype adrenergic antagonists.